Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirusFrancesco Di Pierro, Alexander Bertuccioli, Ilaria Cavecchia Minerva Gastroenterologica e Dietologica 2020 March 12
The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.
Minerva Gastroenterologica e Dietologica 2020 March 12
The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.
AHCC（依诺金）是一种基于α-葡聚糖的标准化蘑菇提取物，在西尼罗病毒、流感病毒、禽流感（H5N1）病毒、人乳头病毒（HPV）、丙型肝炎病毒、疱疹病毒、乙肝病毒和HIV影响的动物和/或人类的免疫刺激剂和保护性的免疫反应研究中，已经证实了依诺金（担子菌菌丝体培养提取物）对病毒和细菌感染的有效性。这些研究表明依诺金激活或增加免疫系统早期防御系统的关键细胞如 NK（自然杀手）细胞、NKT（自然杀手 T）细胞和 γδT（伽马德尔塔T）细胞，因此依诺金对感染性疾病的有效性被认为主要归因于先天免疫系统的激活。此外，在感染以外的领域，还有许多关于依诺金的免疫调节作用的报告。 当前尚无针对新冠病毒有效的疫苗，尽管尚未针对SARS-CoV-2疾病对AHCC的功效进行专门评估，但其在促进对多种病毒感染的保护性反应中的作用已经证实。可以支持AHCC(依诺金)在致病性冠状病毒领域的应用，预防人类致病性冠状病毒引起的疾病，包括COVID-19。 Amazon上有不少AHCC在卖（非广告贴，我也不可能控制卖AHCC的店家 ）, 只是觉得也许有用